Skip to main content
. 2025 Feb 5;97(1):264–276. doi: 10.1227/neu.0000000000003369

TABLE 1.

Patients Demographics From the 3-Month Follow-up Cohort (n = 374)

Age, years (mean ± SD) 48.7 ± 17.1
Male, n (%) 219 (58.6)
Female, n (%) 155 (41.4)
Ethnicity, n (%)
 Caucasian 325 (86.9)
 Black 4 (1.1)
 Asian 14 (3.7)
 Aboriginal 0 (0.0)
 Hispanic 22 (5.9)
 Caribbean 2 (0.5)
 East Indian 3 (0.8)
 Other/mixed 1 (0.3)
 Unknown 3 (0.8)
Charlson Comorbidity Index (mean ± SD) (n = 363) 2.1 ± 1.2
Smoking status, n (%)
 Active 26 (7.0)
 Ancient 36 (9.6)
Previous surgical status (n = 372), n (%)
 First surgery (virgin) 234 (62.9)
 Revision surgery 138 (37.1)
Main tumor location (reclassified), n (%)
 C0-C2 31 (8.3)
 C3-C6 15 (4.0)
 C7-T2 30 (8.1)
 T3-L5 205 (54.8)
 S1-S5/coccyx 93 (24.9)
ECOG performance status (n = 362), n (%)
 0 130 (35.9)
 1 166 (45.9)
 2 43 (11.9)
 3 18 (5.0)
 4 5 (1.4)
 5 0 (0.0)

ECOG, Eastern Cooperative Oncology Group.